Cargando…
Effect of Multiple Sclerosis Cerebrospinal Fluid and Oligodendroglia Cell Line Environment on Human Wharton’s Jelly Mesenchymal Stem Cells Secretome
Multiple sclerosis (MS) is a neurological disorder of autoimmune aetiology. Experimental therapies with the use of mesenchymal stem cells (MSCs) have emerged as a response to the unmet need for new treatment options. The unique immunomodulatory features of stem cells obtained from Wharton’s jelly (W...
Autores principales: | Salwierak-Głośna, Karolina, Piątek, Paweł, Domowicz, Małgorzata, Świderek-Matysiak, Mariola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878514/ https://www.ncbi.nlm.nih.gov/pubmed/35216294 http://dx.doi.org/10.3390/ijms23042177 |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
por: Świderek-Matysiak, Mariola, et al.
Publicado: (2023) -
Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications
por: Drobiova, Hana, et al.
Publicado: (2023) -
Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis
por: Oset, Magdalena, et al.
Publicado: (2023) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome?
por: Teixeira, Fábio G., et al.
Publicado: (2015)